Safety and Efficacy of tPBM for Epileptiform Activity in Autism

Clinical trial NCT06352372 · COMPLETED

Trial details

NCT number: NCT06352372
Sponsor: Richard Frye
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Autism Spectrum Disorder EEG With Periodic Abnormalities Epilepsy Neurodevelopmental Disorders Neurological Disorder

Start date: 2024-07-01
Primary completion: 2026-02-10
Enrollment: 6

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.